Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Richard S. Lindahl
Person

Richard S. Lindahl

Tracked across 1 events · 6 articles · First seen Aug 10, 2026 · Last active Aug 12, 2026

Sentiment
-30
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 -30
Regulatory
Emergent BioSolutions securities fraud investigation
Levi & Korsinsky, LLP has commenced an investigation into Emergent BioSolutions Inc. (NYSE: EBS) concerning potential violations of federal securities laws. The investigation focuses on whether Emergent adequately disclosed the deterioration in its Naloxone franchise,…
Impact: Richard S. Lindahl, CFO of Emergent BioSolutions, made statements attributing softer Naloxone demand to transient factors. His statements are part of the investigation into potentially misleading disclosures.
Aug 10, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Richard S. Lindahl live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.